DM
Drugs Made In America Acquisition Corp. Units (DMAAU)
NASDAQ·Financial Services·Financial - Conglomerates
$11.32
—
Mkt Cap $247.19M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$233.45
Range $158.34 – $274.05
Implied Upside
+1962.3%
Consensus $233.45 vs current $11.32